Literature DB >> 31243240

Decrease in Butyrylcholinesterase Accompanied by Intermediate-like Syndrome after Massive Ingestion of a Glyphosate-surfactant.

Ikuto Takeuchi1, Youichi Yanagawa1, Hiroki Nagasawa1, Kei Jitsuiki1, Shunsuke Madokoro1, Norihito Takahashi1, Hiromichi Ohsaka1, Kouhei Ishikawa1, Kazuhiko Omori1.   

Abstract

An 86-year-old woman intentionally drank approximately 300 mL of a glyphosate-surfactant. She was found with consciousness disturbance and experienced several vomiting episodes. On arrival, serum biochemistry revealed a decreased level of butyrylcholinesterase (B-CHE) [11 (normal range: 180-450) IU/L]. Later, her B-CHE level further decreased to single-digit values, and she became comatose with involuntary movement and an increase in muscle tone. Her consciousness level and muscle tone improved with the recovery of her B-CHE level. Physicians should be alert for the occurrence of intermediate syndrome when the B-CHE levels of patients who have consumed a massive amount of glyphosate-surfactant show a prolonged decrease.

Entities:  

Keywords:  butyrylcholinesterase; glyphosate-surfactant; intermediate syndrome

Mesh:

Substances:

Year:  2019        PMID: 31243240      PMCID: PMC6859399          DOI: 10.2169/internalmedicine.2562-18

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Glyphosate-surfactants are commonly used pesticides that are thought to be safer than paraquat. When used normally, these agents do not induce adverse effects on the development or on the reproductive or endocrine systems in humans or other animals (1). Paraquat has not been sold since 1999, and glyphosate-surfactant can be purchased without any regulations in Japan. A hospital-based survey of clinical cases of pesticide acute poisoning revealed glyphosate-surfactant to be the most frequent cause among 137 cases (2). Acute poisoning symptoms induced by a glyphosate-surfactant include gastrointestinal symptoms, respiratory distress, hypotension, altered consciousness and renal insufficiency (3-5). However, no studies have reported the induction of a decrease in the butyrylcholinesterase (B-CHE) level or intermediate syndrome (typical symptoms of organophosphate poisoning) by glyphosate-surfactants. We herein report the case of a patient with a transient decrease in her B-CHE level, which was accompanied by intermediate-like syndrome, following the ingestion of a massive amount of a glyphosate-surfactant.

Case Report

An 86-year-old woman intentionally drank approximately 300 mL of a glyphosate-surfactant, which had been bought for her kitchen garden, after a quarrel with her daughter. She was found by her daughter with consciousness disturbance, having experienced several vomiting episodes. She had depression and a history of overdose. She was transported to our hospital by a physician-staffed helicopter. Upon arrival, her vital signs were as follows: Glasgow Coma Scale (GCS), E3V3M6; blood pressure, 108/76 mmHg; pulse rate, 66 beats per minute; respiratory rate, 30 breaths per minute and saturation of peripheral oxygen with oxygen of 10 L per minute, 100%. Her pupils were 2 mm in size with prompt light reflex. The physiological findings on muscle tone, chest roentgenography and electrocardiography studies were negative. Serum biochemistry revealed a decreased level of B-CHE [11 (normal range: 180-450) IU/L] (Table). The patient underwent cathartic and activated charcoal treatment after gastric lavage. She was admitted to our hospital, and her cardio-respiratory function was continuously monitored. Figure shows the time course in her B-CHE level, GCS and muscle tone.
Table.

Results of the Blood Analyses on Arrival.

Blood gas analysis: (on 10 L min-1 of oxygen)
pH7.406PCO241.0mmHgPO275.6mmHg
HCO3-25.3mmol/LBase excess1.0mmol/L
Cell blood count and biochemical analysis
White blood cells16.0×103/µLHemoglobin12.1g/dL
Platelets20.1×104/µL
Total protein7.4g/dLButyrylcholinesterase11 (180-450)IU/L
Aspartate aminotransferase20IU/LAlanine aminotransferase10IU/L
Alkaline phosphatase157IU/Lγ-glutamyltransferase10IU/L
Creatine phosphokinase54IU/LAmylase160IU/L
Blood urea nitrogen18.6mg/dLCreatinine0.66mg/dL
Glucose182mg/dLSodium136mEq/L
Potassium3.1mEq/LChloride102mEq/L
C-reactive protein0.3mg/dLFibrinogen209mg/dL
Activated partial thromboplastin time19.2 (24.9)s
Prothrombin time10.7 (11.7)s
Fibrinogen degradation products5.2µg/mL
Figure.

Time course of B-CHE, GCS and muscle tone. The improvement in the GCS score was correlated with the recovery of the patient’s B-CHE level. The patient’s muscle tone also improved after the recovery of her B-CHE level. B-CHE: butyrylcholinesterase, GCS: Glasgow Coma Scale

Results of the Blood Analyses on Arrival. On the second day, she complained of pain with delirium, but her physical and laboratory findings showed no remarkable changes. On the third day, she became alert and was able to drink water. Her peripheral oxygen improved to the normal range under room air. On the fourth and fifth days, her B-CHE levels further decreased to single-digit values; however, she was asymptomatic. On the sixth day, she developed consciousness disturbance and involuntary movement with an increase in muscle tone. Urgent head magnetic resonance imaging and electroencephalography showed negative findings. She temporarily showed apnea with reduced peripheral oxygen but obtained spontaneous respiration. On the seventh day, she became comatose. On the ninth day, her GCS score improved, but she displayed catalepsy-like movement. On the 13th day, she showed convulsions, which were treated by levetiracetam. Her consciousness level and muscle tone improved according to the recovery of her B-CHE level. Her symptoms improved further the next day, and she was eventually able to feed herself and walk. As the patient's condition was complicated by depression, she was transported to a psychiatric hospital. Time course of B-CHE, GCS and muscle tone. The improvement in the GCS score was correlated with the recovery of the patient’s B-CHE level. The patient’s muscle tone also improved after the recovery of her B-CHE level. B-CHE: butyrylcholinesterase, GCS: Glasgow Coma Scale

Discussion

This is the first case of glyphosate-surfactant poisoning to be accompanied by a transient decrease in the B-CHE level and intermediate-like syndrome. There have been no clinical reports describing cases in which the ingestion of a large amount of glyphosate-surfactant resulted in a severe and prolonged decrease in a patient's B-CHE level. Accordingly, we were unable to clarify whether or not this severe effect on the B-CHE level after the ingestion of a large amount of glyphosate-surfactant occurs in all humans. In normal use, glyphosate-surfactant does not alter the levels of B-CHE (6). However, in some species, glyphosate-surfactant can reduce the level of acetylcholinesterase (A-CHE) in erythrocytes, brain and muscle (7). Glyphosate-surfactant can also reduce the level of B-CHE in massive doses (8). B-CHE can act as a backup for acetylcholinesterase and as a scavenger for poisons that might inhibit acetylcholinesterase activity (9). In organophosphate-induced neurotoxicity, A-CHE and/or B-CHE inhibition was found to be correlated with the occurrence of intermediate syndrome (10). In addition, Yilmaz et al. prospectively performed therapeutic plasma exchange for patients who developed intermediate syndrome during follow-up for organophosphate intoxication (11). As a result, a statistically significant increase was detected in the plasma B-CHE levels of patients after therapeutic plasma exchange. Thirteen of 17 patients showed clinical improvement and were discharged after therapeutic plasma exchange. These results suggested that low levels of B-CHE have the potential to induce intermediate syndrome. Accordingly, the ingestion of a massive amount of glyphosate-surfactant may reduce the level of B-CHE, even in humans, which has the potential to induce intermediate syndrome, similarly to organophosphate poisoning.

Conclusion

Physicians should pay attention to the occurrence of intermediate syndrome when the B-CHE levels of patients who have ingested a massive amount of a glyphosate-surfactant are decreased for a prolonged period of time.

The authors state that they have no Conflict of Interest (COI).

Financial Support

This manuscript obtained financial support from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities, 2015-2019 [The constitution of total researching system for comprehensive disaster, medical management, corresponding to wide-scale disaster].
  10 in total

1.  Clinical presentations and prognostic factors of a glyphosate-surfactant herbicide intoxication: a review of 131 cases.

Authors:  H L Lee; K W Chen; C H Chi; J J Huang; L M Tsai
Journal:  Acad Emerg Med       Date:  2000-08       Impact factor: 3.451

Review 2.  [Glyphosate and its formulations--toxicity, occupational and environmental exposure].

Authors:  Marta Kwiatkowska; Jarosiewicz Paweł; Bozena Bukowska
Journal:  Med Pr       Date:  2013       Impact factor: 0.760

3.  Epidemiology of organophosphate intoxication and predictors of intermediate syndrome.

Authors:  Şahin Çolak; Mehmet Özgür Erdoğan; Ahmet Baydin; Mustafa Ahmet Afacan; Celal Kati; Latif Duran
Journal:  Turk J Med Sci       Date:  2014       Impact factor: 0.973

Review 4.  Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans.

Authors:  G M Williams; R Kroes; I C Munro
Journal:  Regul Toxicol Pharmacol       Date:  2000-04       Impact factor: 3.271

5.  Toxicity of four herbicide formulations with glyphosate on Rhinella arenarum (anura: bufonidae) tadpoles: B-esterases and glutathione S-transferase inhibitors.

Authors:  Rafael C Lajmanovich; Andrés M Attademo; Paola M Peltzer; Celina M Junges; Mariana C Cabagna
Journal:  Arch Environ Contam Toxicol       Date:  2010-07-29       Impact factor: 2.804

Review 6.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

7.  Effectiveness of therapeutic plasma exchange in patients with intermediate syndrome due to organophosphate intoxication.

Authors:  Mustafa Yilmaz; Ahmet Sebe; Mehmet Oguzhan Ay; Umut Gumusay; Metin Topal; Mesude Atli; Ferhat Icme; Salim Satar
Journal:  Am J Emerg Med       Date:  2013-05-17       Impact factor: 2.469

8.  The epidemiology of glyphosate-surfactant herbicide poisoning in Taiwan, 1986-2007: a poison center study.

Authors:  Ying-Ju Chen; Ming-Ling Wu; Jou-Fang Deng; Chen-Chang Yang
Journal:  Clin Toxicol (Phila)       Date:  2009-08       Impact factor: 4.467

9.  The herbicide glyphosate is a weak inhibitor of acetylcholinesterase in rats.

Authors:  Karen E Larsen; Adrián L Lifschitz; Carlos E Lanusse; Guillermo L Virkel
Journal:  Environ Toxicol Pharmacol       Date:  2016-05-18       Impact factor: 4.860

10.  A prospective observational study of the clinical toxicology of glyphosate-containing herbicides in adults with acute self-poisoning.

Authors:  Darren M Roberts; Nick A Buckley; Fahim Mohamed; Michael Eddleston; Daniel A Goldstein; Akbar Mehrsheikh; Marian S Bleeke; Andrew H Dawson
Journal:  Clin Toxicol (Phila)       Date:  2010-02       Impact factor: 4.467

  10 in total
  1 in total

1.  Neurotoxicity Assessment of Four Different Pesticides Using In Vitro Enzymatic Inhibition Assays.

Authors:  Carlos Martins-Gomes; Tiago E Coutinho; Tânia L Silva; Tatiana Andreani; Amélia M Silva
Journal:  Toxics       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.